Cargando…
The role of transcription factor Yin Yang‐1 in colorectal cancer
BACKGROUND: Yin Yang‐1 (YY1) is identified as a transcription factor with multiple functions. However, the role of YY1 in tumorigenesis remains controversial and its regulatory effects may depend upon not only cancer types, but also its interacting partners, chromatin structure, and the context in w...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242864/ https://www.ncbi.nlm.nih.gov/pubmed/36880159 http://dx.doi.org/10.1002/cam4.5745 |
_version_ | 1785054311269531648 |
---|---|
author | Shao, Zhiying Yang, Wendong Meng, Xiannan Li, Minle Hou, Pingfu Li, Zhongwei Chu, Sufang Zheng, Junnian Bai, Jin |
author_facet | Shao, Zhiying Yang, Wendong Meng, Xiannan Li, Minle Hou, Pingfu Li, Zhongwei Chu, Sufang Zheng, Junnian Bai, Jin |
author_sort | Shao, Zhiying |
collection | PubMed |
description | BACKGROUND: Yin Yang‐1 (YY1) is identified as a transcription factor with multiple functions. However, the role of YY1 in tumorigenesis remains controversial and its regulatory effects may depend upon not only cancer types, but also its interacting partners, chromatin structure, and the context in which it acts. It has been detected that YY1 was highly expressed in colorectal cancer (CRC). Intriguingly, many YY1‐repressed genes exhibit tumor suppressive potential while YY1 silencing is related to chemotherapy resistance. Therefore, it is crucial to meticulously explore YY1 protein structure and the dynamic alteration of its interactome in each cancer type. This review attempts to describe the structure of YY1, summarize the mechanism that influence the expression level of YY1 and also highlight the recent advances in our understanding of regulatory insights of YY1 functions in CRC. METHODS: Related studies were identified through scoping search of PubMed, Web of science, Scopus and Emhase concerning the terms of “colorectal cancer”, colorectal carcinoma” or CRC with “YY1”. The retrieval strategy included title, abstract, and keywords with no language limitations. All the included articles were categorized depending on the mechanisms they explored. RESULTS: In total, 170 articles were identified for further screening. After removing the duplication, not relevant outcomes and review articles, 34 were finally included in the review. Among them, 10 articles revealed the reasons of YY1 high expression in CRC, 13 articles explored YY1 function in CRC, and 11 articles fell into both aspects. In addition, we also summarized 10 clinical trials concerning the expression and activity of YY1 in various diseases, which offers a hint for future application. CONCLUSIONS: YY1 is highly expressed in CRC and broadly recognized as an oncogenic factor during the whole course of CRC. Sporadic controversial views are raised in term of CRC treatment, reminding us that future studies should take the influence of therapeutic regimens into concern. |
format | Online Article Text |
id | pubmed-10242864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102428642023-06-07 The role of transcription factor Yin Yang‐1 in colorectal cancer Shao, Zhiying Yang, Wendong Meng, Xiannan Li, Minle Hou, Pingfu Li, Zhongwei Chu, Sufang Zheng, Junnian Bai, Jin Cancer Med REVIEWS BACKGROUND: Yin Yang‐1 (YY1) is identified as a transcription factor with multiple functions. However, the role of YY1 in tumorigenesis remains controversial and its regulatory effects may depend upon not only cancer types, but also its interacting partners, chromatin structure, and the context in which it acts. It has been detected that YY1 was highly expressed in colorectal cancer (CRC). Intriguingly, many YY1‐repressed genes exhibit tumor suppressive potential while YY1 silencing is related to chemotherapy resistance. Therefore, it is crucial to meticulously explore YY1 protein structure and the dynamic alteration of its interactome in each cancer type. This review attempts to describe the structure of YY1, summarize the mechanism that influence the expression level of YY1 and also highlight the recent advances in our understanding of regulatory insights of YY1 functions in CRC. METHODS: Related studies were identified through scoping search of PubMed, Web of science, Scopus and Emhase concerning the terms of “colorectal cancer”, colorectal carcinoma” or CRC with “YY1”. The retrieval strategy included title, abstract, and keywords with no language limitations. All the included articles were categorized depending on the mechanisms they explored. RESULTS: In total, 170 articles were identified for further screening. After removing the duplication, not relevant outcomes and review articles, 34 were finally included in the review. Among them, 10 articles revealed the reasons of YY1 high expression in CRC, 13 articles explored YY1 function in CRC, and 11 articles fell into both aspects. In addition, we also summarized 10 clinical trials concerning the expression and activity of YY1 in various diseases, which offers a hint for future application. CONCLUSIONS: YY1 is highly expressed in CRC and broadly recognized as an oncogenic factor during the whole course of CRC. Sporadic controversial views are raised in term of CRC treatment, reminding us that future studies should take the influence of therapeutic regimens into concern. John Wiley and Sons Inc. 2023-03-06 /pmc/articles/PMC10242864/ /pubmed/36880159 http://dx.doi.org/10.1002/cam4.5745 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | REVIEWS Shao, Zhiying Yang, Wendong Meng, Xiannan Li, Minle Hou, Pingfu Li, Zhongwei Chu, Sufang Zheng, Junnian Bai, Jin The role of transcription factor Yin Yang‐1 in colorectal cancer |
title | The role of transcription factor Yin Yang‐1 in colorectal cancer |
title_full | The role of transcription factor Yin Yang‐1 in colorectal cancer |
title_fullStr | The role of transcription factor Yin Yang‐1 in colorectal cancer |
title_full_unstemmed | The role of transcription factor Yin Yang‐1 in colorectal cancer |
title_short | The role of transcription factor Yin Yang‐1 in colorectal cancer |
title_sort | role of transcription factor yin yang‐1 in colorectal cancer |
topic | REVIEWS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242864/ https://www.ncbi.nlm.nih.gov/pubmed/36880159 http://dx.doi.org/10.1002/cam4.5745 |
work_keys_str_mv | AT shaozhiying theroleoftranscriptionfactoryinyang1incolorectalcancer AT yangwendong theroleoftranscriptionfactoryinyang1incolorectalcancer AT mengxiannan theroleoftranscriptionfactoryinyang1incolorectalcancer AT liminle theroleoftranscriptionfactoryinyang1incolorectalcancer AT houpingfu theroleoftranscriptionfactoryinyang1incolorectalcancer AT lizhongwei theroleoftranscriptionfactoryinyang1incolorectalcancer AT chusufang theroleoftranscriptionfactoryinyang1incolorectalcancer AT zhengjunnian theroleoftranscriptionfactoryinyang1incolorectalcancer AT baijin theroleoftranscriptionfactoryinyang1incolorectalcancer AT shaozhiying roleoftranscriptionfactoryinyang1incolorectalcancer AT yangwendong roleoftranscriptionfactoryinyang1incolorectalcancer AT mengxiannan roleoftranscriptionfactoryinyang1incolorectalcancer AT liminle roleoftranscriptionfactoryinyang1incolorectalcancer AT houpingfu roleoftranscriptionfactoryinyang1incolorectalcancer AT lizhongwei roleoftranscriptionfactoryinyang1incolorectalcancer AT chusufang roleoftranscriptionfactoryinyang1incolorectalcancer AT zhengjunnian roleoftranscriptionfactoryinyang1incolorectalcancer AT baijin roleoftranscriptionfactoryinyang1incolorectalcancer |